Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study

Go back to Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study
Pfizer Inc. (NYSE: PFE) Delayed: 29.82 -0.29 (0.96%)
Previous Close $30.11    52 Week High $37.39 
Open $30.00    52 Week Low $28.25 
Day High $30.09    P/E 18.07 
Day Low $29.72    EPS $1.65 
Volume 7,542,226